Terrytown, NY, United States of America

Alshad S Lalani



Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Tarrytown, NY (US) (2011)
  • Briarcliff Manor, NY (US) (2013)
  • Terrytown, NY (US) (2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Alshad S Lalani: Innovator in Pharmaceutical Sciences

Introduction

Alshad S Lalani is a notable inventor based in Terrytown, NY (US), recognized for his contributions to the field of pharmaceutical sciences. He holds three patents that focus on innovative treatments for hyperproliferative diseases. His work has significant implications for the development of new therapeutic agents.

Latest Patents

Lalani's latest patents include the treatment of hyperproliferative diseases with vinca alkaloid N-oxide analogs. This invention relates to vinca alkaloid and analog N-oxides that exhibit activity in treating hyperproliferative disorders. Additionally, he has developed pharmaceutical compositions and methods for using these compounds, either alone or in combination with other active agents, to effectively address hyperproliferative disorders. Another significant patent involves Mannich base N-oxide drugs, which disclose Mannich base N-oxides of drugs containing acidic N—H groups. This patent also includes pharmaceutical compositions comprising a therapeutically effective amount of Mannich base N-oxides, along with methods for their use.

Career Highlights

Throughout his career, Alshad S Lalani has worked with various organizations, including Cascade Prodrug Inc. and the University of Oregon. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

Lalani has collaborated with notable colleagues such as John F W Keana and Paul B Westberg. These partnerships have likely enhanced his research and innovation efforts in the pharmaceutical field.

Conclusion

Alshad S Lalani's work in developing innovative treatments for hyperproliferative diseases showcases his significant contributions to pharmaceutical sciences. His patents reflect a commitment to advancing medical therapies and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…